191 related articles for article (PubMed ID: 17095512)
1. Substrate conformation modulates aggrecanase (ADAMTS-4) affinity and sequence specificity. Suggestion of a common topological specificity for functionally diverse proteases.
Lauer-Fields JL; Minond D; Sritharan T; Kashiwagi M; Nagase H; Fields GB
J Biol Chem; 2007 Jan; 282(1):142-50. PubMed ID: 17095512
[TBL] [Abstract][Full Text] [Related]
2. Kinetic analysis of matrix metalloproteinase activity using fluorogenic triple-helical substrates.
Lauer-Fields JL; Broder T; Sritharan T; Chung L; Nagase H; Fields GB
Biochemistry; 2001 May; 40(19):5795-803. PubMed ID: 11341845
[TBL] [Abstract][Full Text] [Related]
3. Low density lipoprotein receptor-related protein 1 (LRP1)-mediated endocytic clearance of a disintegrin and metalloproteinase with thrombospondin motifs-4 (ADAMTS-4): functional differences of non-catalytic domains of ADAMTS-4 and ADAMTS-5 in LRP1 binding.
Yamamoto K; Owen K; Parker AE; Scilabra SD; Dudhia J; Strickland DK; Troeberg L; Nagase H
J Biol Chem; 2014 Mar; 289(10):6462-6474. PubMed ID: 24474687
[TBL] [Abstract][Full Text] [Related]
4. The thrombospondin motif of aggrecanase-1 (ADAMTS-4) is critical for aggrecan substrate recognition and cleavage.
Tortorella M; Pratta M; Liu RQ; Abbaszade I; Ross H; Burn T; Arner E
J Biol Chem; 2000 Aug; 275(33):25791-7. PubMed ID: 10827174
[TBL] [Abstract][Full Text] [Related]
5. Analysis of flavonoid-based pharmacophores that inhibit aggrecanases (ADAMTS-4 and ADAMTS-5) and matrix metalloproteinases through the use of topologically constrained peptide substrates.
Cudic M; Burstein GD; Fields GB; Lauer-Fields J
Chem Biol Drug Des; 2009 Nov; 74(5):473-82. PubMed ID: 19793184
[TBL] [Abstract][Full Text] [Related]
6. Identification of an ADAMTS-4 cleavage motif using phage display leads to the development of fluorogenic peptide substrates and reveals matrilin-3 as a novel substrate.
Hills R; Mazzarella R; Fok K; Liu M; Nemirovskiy O; Leone J; Zack MD; Arner EC; Viswanathan M; Abujoub A; Muruganandam A; Sexton DJ; Bassill GJ; Sato AK; Malfait AM; Tortorella MD
J Biol Chem; 2007 Apr; 282(15):11101-9. PubMed ID: 17311924
[TBL] [Abstract][Full Text] [Related]
7. Proteolytic activities of human ADAMTS-5: comparative studies with ADAMTS-4.
Gendron C; Kashiwagi M; Lim NH; Enghild JJ; Thøgersen IB; Hughes C; Caterson B; Nagase H
J Biol Chem; 2007 Jun; 282(25):18294-18306. PubMed ID: 17430884
[TBL] [Abstract][Full Text] [Related]
8. TIMP-3 inhibition of ADAMTS-4 (Aggrecanase-1) is modulated by interactions between aggrecan and the C-terminal domain of ADAMTS-4.
Wayne GJ; Deng SJ; Amour A; Borman S; Matico R; Carter HL; Murphy G
J Biol Chem; 2007 Jul; 282(29):20991-8. PubMed ID: 17470431
[TBL] [Abstract][Full Text] [Related]
9. Alpha2-macroglobulin is a novel substrate for ADAMTS-4 and ADAMTS-5 and represents an endogenous inhibitor of these enzymes.
Tortorella MD; Arner EC; Hills R; Easton A; Korte-Sarfaty J; Fok K; Wittwer AJ; Liu RQ; Malfait AM
J Biol Chem; 2004 Apr; 279(17):17554-61. PubMed ID: 14715656
[TBL] [Abstract][Full Text] [Related]
10. Aggrecanase and aggrecan degradation in osteoarthritis: a review.
Huang K; Wu LD
J Int Med Res; 2008; 36(6):1149-60. PubMed ID: 19094423
[TBL] [Abstract][Full Text] [Related]
11. Domains and maturation processes that regulate the activity of ADAMTS-2, a metalloproteinase cleaving the aminopropeptide of fibrillar procollagens types I-III and V.
Colige A; Ruggiero F; Vandenberghe I; Dubail J; Kesteloot F; Van Beeumen J; Beschin A; Brys L; Lapière CM; Nusgens B
J Biol Chem; 2005 Oct; 280(41):34397-408. PubMed ID: 16046392
[TBL] [Abstract][Full Text] [Related]
12. Functional differences of the catalytic and non-catalytic domains in human ADAMTS-4 and ADAMTS-5 in aggrecanolytic activity.
Fushimi K; Troeberg L; Nakamura H; Lim NH; Nagase H
J Biol Chem; 2008 Mar; 283(11):6706-16. PubMed ID: 18156631
[TBL] [Abstract][Full Text] [Related]
13. Hydrolysis of triple-helical collagen peptide models by matrix metalloproteinases.
Lauer-Fields JL; Tuzinski KA; Shimokawa Ki; Nagase H; Fields GB
J Biol Chem; 2000 May; 275(18):13282-90. PubMed ID: 10788434
[TBL] [Abstract][Full Text] [Related]
14. Screening of potential a disintegrin and metalloproteinase with thrombospondin motifs-4 inhibitors using a collagen model fluorescence resonance energy transfer substrate.
Lauer-Fields JL; Spicer TP; Chase PS; Cudic M; Burstein GD; Nagase H; Hodder P; Fields GB
Anal Biochem; 2008 Feb; 373(1):43-51. PubMed ID: 17949675
[TBL] [Abstract][Full Text] [Related]
15. Altered proteolytic activities of ADAMTS-4 expressed by C-terminal processing.
Kashiwagi M; Enghild JJ; Gendron C; Hughes C; Caterson B; Itoh Y; Nagase H
J Biol Chem; 2004 Mar; 279(11):10109-19. PubMed ID: 14662755
[TBL] [Abstract][Full Text] [Related]
16. Selective hydrolysis of triple-helical substrates by matrix metalloproteinase-2 and -9.
Lauer-Fields JL; Sritharan T; Stack MS; Nagase H; Fields GB
J Biol Chem; 2003 May; 278(20):18140-5. PubMed ID: 12642591
[TBL] [Abstract][Full Text] [Related]
17. The C-terminal domains of ADAMTS-4 and ADAMTS-5 promote association with N-TIMP-3.
Troeberg L; Fushimi K; Scilabra SD; Nakamura H; Dive V; Thøgersen IB; Enghild JJ; Nagase H
Matrix Biol; 2009 Oct; 28(8):463-9. PubMed ID: 19643179
[TBL] [Abstract][Full Text] [Related]
18. Development of human neutralizing antibody to ADAMTS4 (aggrecanase-1) and ADAMTS5 (aggrecanase-2).
Shiraishi A; Mochizuki S; Miyakoshi A; Kojoh K; Okada Y
Biochem Biophys Res Commun; 2016 Jan; 469(1):62-69. PubMed ID: 26612259
[TBL] [Abstract][Full Text] [Related]
19. Activity of ADAM17 (a disintegrin and metalloprotease 17) is regulated by its noncatalytic domains and secondary structure of its substrates.
Stawikowska R; Cudic M; Giulianotti M; Houghten RA; Fields GB; Minond D
J Biol Chem; 2013 Aug; 288(31):22871-9. PubMed ID: 23779109
[TBL] [Abstract][Full Text] [Related]
20. Glycosaminoglycan-binding properties and aggrecanase activities of truncated ADAMTSs: comparative analyses with ADAMTS-5, -9, -16 and -18.
Zeng W; Corcoran C; Collins-Racie LA; Lavallie ER; Morris EA; Flannery CR
Biochim Biophys Acta; 2006 Mar; 1760(3):517-24. PubMed ID: 16507336
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
